Avicanna Inc. (OTCMKTS:AVCNF) Short Interest Down 80.0% in June

Posted by on Jun 27th, 2026

Avicanna Inc. (OTCMKTS:AVCNF – Get Free Report) was the target of a significant drop in short interest during the month of June. As of June 15th, there was short interest totaling 40,987 shares, a drop of 80.0% from the May 31st total of 204,945 shares. Based on an average trading volume of 305,425 shares, the short-interest ratio is currently 0.1 days.

Avicanna Stock Performance

Shares of AVCNF opened at $0.09 on Friday. Avicanna has a fifty-two week low of $0.07 and a fifty-two week high of $0.24. The firm has a 50 day moving average price of $0.10 and a 200-day moving average price of $0.13.

About Avicanna

(Get Free Report)

Avicanna Inc, a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets worldwide. It commercializes approximately thirty proprietary evidence-based finished products. The company provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand; and indication-specific pharmaceutical products to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders, such as Trunerox, an adjuvant treatment for seizures associated with Lennox-Gastaut Syndrome and Dravet Syndrome.

Recommended Stories

Receive News & Ratings for Avicanna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avicanna and related companies with MarketBeat.com's FREE daily email newsletter.